Alta Advisers’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$390K Hold
4,985
0.09% 109
2026
Q1
$432K Hold
4,985
0.16% 96
2025
Q4
$479K Sell
4,985
-1,300
-21% -$126K 0.17% 90
2025
Q3
$599K Hold
6,285
0.18% 93
2025
Q2
$548K Hold
6,285
0.2% 96
2025
Q1
$565K Buy
6,285
+2,100
+50% +$188K 0.24% 86
2024
Q4
$334K Buy
4,185
+685
+20% +$59.3K 0.21% 94
2024
Q3
$315K Hold
3,500
0.14% 85
2024
Q2
$275K Hold
3,500
0.13% 91
2024
Q1
$305K Hold
3,500
0.15% 82
2023
Q4
$288K Hold
3,500
0.15% 79
2023
Q3
$274K Hold
3,500
0.16% 75
2023
Q2
$308K Hold
3,500
0.17% 70
2023
Q1
$282K Hold
3,500
0.17% 73
2022
Q4
$272K Hold
3,500
0.16% 76
2022
Q3
$283K Buy
+3,500
New +$315K 0.18% 63

Other funds holding MDT

Alta Advisers's MDT Position: Q2 2026 in Review

Alta Advisers held its Medtronic (MDT) position steady in Q2 2026 at 4,985 shares worth $390K. The position accounts for 0.09% of the portfolio, ranked #109.

Alta Advisers first reported a position in MDT in Q3 2022 and has held it in 16 quarters since. The position peaked at $599K in Q3 2025. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Alta Advisers held 4,985 shares of Medtronic worth $390K as of Q2 2026.
  • Alta Advisers left its Medtronic share count unchanged in Q2 2026.
  • Medtronic made up 0.09% of Alta Advisers's portfolio in Q2 2026, its #109 holding.
  • Alta Advisers first reported a position in Medtronic in Q3 2022 and has held it in 16 quarters since.
  • Alta Advisers's Medtronic position peaked at $599K in Q3 2025.
  • 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Alta Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.